HR-9048-119
Referred to the House Committee on Energy and Commerce.
Sponsored by Emanuel Cleaver (D-MO)
What it does
This bill would amend the Federal Food, Drug, and Cosmetic Act to add "gluten-containing grain" — defined as wheat (genus Triticum), rye (genus Secale), barley (genus Hordeum), and their crossbred hybrids such as triticale — to the official list of major food allergens. Currently, only wheat is listed as a major food allergen; rye and barley are not. Adding these grains would require food manufacturers to disclose their presence on product labels. The new labeling requirements would take effect 18 months after enactment.
Who benefits
The approximately 3 million Americans diagnosed with celiac disease, who must avoid all gluten-containing grains — not just wheat — to prevent serious intestinal damage. People with non-celiac gluten sensitivity, estimated at 6–7% of the U.S. population. Parents of children with these conditions who rely on food labels to make safe purchasing decisions. Gastroenterologists and dietitians who counsel patients on gluten-free diets. Gluten-free food manufacturers who may gain a competitive advantage as labeling requirements expand consumer awareness.
Who is hurt
Food manufacturers who use rye or barley as ingredients and would need to update packaging, supply chain documentation, and labeling systems within 18 months. Small and mid-size food producers with limited compliance budgets who may face proportionally higher costs. Brewers and distillers who use barley, as expanded allergen labeling could affect product formulation disclosures. Consumers could see modest price increases if manufacturers pass compliance costs through to retail prices.
Supporters argue
Supporters argue that the current allergen framework is medically inconsistent: celiac disease is triggered by gluten in wheat, rye, and barley equally, yet only wheat carries a mandatory allergen label. They contend that patients with celiac disease face serious, measurable health consequences — including intestinal damage and increased cancer risk — when they unknowingly consume rye or barley, and that clear labeling is the most direct way to prevent those harms. The 18-month compliance window, they argue, gives industry adequate time to adjust without leaving patients at risk indefinitely.
Opponents argue
Opponents argue that celiac disease is an autoimmune condition, not a true IgE-mediated food allergy, and that expanding the statutory allergen definition to cover it conflates two distinct medical categories, potentially diluting the urgency of the existing allergen warning system for people with life-threatening anaphylactic allergies. They contend that the FDA's existing "gluten-free" labeling rule (21 C.F.R. § 101.91), finalized in 2013, already requires foods labeled "gluten-free" to contain fewer than 20 ppm of gluten, providing an existing disclosure pathway — and that adding rye and barley to the allergen list may create redundant regulatory burdens without proportionate safety gains.